Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme

OBJECT: Gliadel (BCNU) wafer and concomitant temozolomide (TMZ) therapy, when used individually as adjuvant therapies, extend survival from that achieved by resection and radiation therapy (XRT) for glioblastoma multiforme (GBM). It remains unstudied whether combining Gliadel and TMZ therapy is safe...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Neurosurg
Auteurs principaux: McGirt, Matthew J., Than, Khoi D., Weingart, Jon D., Chaichana, Kaisorn L., Attenello, Frank J., Olivi, Alessandro, Laterra, John, Kleinberg, Lawrence R., Grossman, Stuart A., Brem, Henry, Quiñones-Hinojosa, Alfredo
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4856017/
https://ncbi.nlm.nih.gov/pubmed/19046047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2008.5.17557
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires